ArticlePatient preference and adherence2025
Real-World Acne Treatment Patterns, Preferences, and Adherence in Thailand: A Cross-Sectional Analysis.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Procedural Treatments as Adjuncts in the Management of Acne Vulgaris: A Narrative Review.Journal of cosmetic dermatology · 2026Review
- Nanoformulations in Acne Therapy: Translational Opportunities and Barriers for Next-Generation Topical Treatments.AAPS PharmSciTech · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acne vulgaris is a common, chronic skin condition that affects both physical appearance and psychological well-being. Effective management requires long-term, personalized strategies that prioritize maintenance and adherence. Most research has focused on Western populations, primarily examining topical and oral therapies, while procedural treatments are more prevalent in Thailand. This study aims to explore treatment preferences among individuals with acne, the factors influencing their choices, and adherence patterns. Materials and Methods: A cross-sectional survey was conducted among 1,237 Thai participants aged 18 to 45 years, utilizing a validated 22-item self-administered questionnaire. The questionnaire assessed demographics, treatment usage, preferences, decision-making factors, satisfaction, and adherence. Statistical analyses included descriptive statistics, chi-square tests, t-tests, and multivariate logistic regression analyses. Results: Topical treatments were the most used (68.07%), although only 16.25% of patients relied on them alone. Comedone extraction was reported by 51.90% of patients, and 42.28% used over-the-counter products. Oral therapies were less common, with antibiotics used by 16.01% and isotretinoin by 10.67%. Overall, most patients reported using combination therapies. The treatment preferences of the participants closely aligned with their actual usage. Adherence to acne treatment was only observed in 33.71% of participants. Factors significantly associated with higher adherence included a longer treatment duration, the use of multiple treatment modalities, a greater impact of acne on quality of life, and high satisfaction with treatment and communication with healthcare providers. Key barriers to adherence included the cost of treatment, lack of noticeable results, and side effects. Conclusion: This study reveals real-world patterns of acne treatment in Thailand, where patients commonly favor topical and procedural therapies, while oral treatments are underutilized. Gender differences, cultural norms, and social influences shape choices. These findings underscore the need for culturally sensitive patient education and evidence-based guidance to improve adherence, satisfaction, and treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.